NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme present in every living cell, central to cellular energy metabolism and DNA repair.
🔬 Studied for: Cellular Energy Research
💊 Also studied for: Longevity & Sirtuin Research
🧪 Not FDA-approved — sold strictly for laboratory research
📈 No standardized human dosage established in published literature
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme present in every living cell, central to cellular energy metabolism and DNA repair. Because NAD+ levels are known to decline with age, it has become a major focus of longevity and metabolic-aging research over the past decade.
NAD+ functions as an essential cofactor in mitochondrial ATP production and serves as a substrate for sirtuins and PARP enzymes, both of which are implicated in DNA repair and cellular stress responses — pathways central to current aging-biology research.
These are effects NAD+ has been studied for in available preclinical and early research — not claims about guaranteed outcomes.
Because NAD+ is a direct participant in mitochondrial electron-transport chain reactions, it is widely studied in research examining cellular energy production and metabolic function across tissue types.
NAD+ availability is a rate-limiting factor for sirtuin enzyme activity, which has made it a central subject in preclinical research on cellular aging, caloric-restriction mimetics, and mitochondrial health.
Doses used in research and clinical infusion settings vary substantially by administration route and study design. There is no single standardized research-use dosage for NAD+.
Compound X does not provide dosing recommendations. NAD+ is sold for laboratory research use only and is not intended for human consumption.
NAD+ precursors (such as NMN and NR) have been studied in human clinical trials, but direct NAD+ administration research is comparatively limited. Reported concerns with NAD+ infusions in available reports include injection-site or infusion-related discomfort and flushing; comprehensive long-term human safety data is still developing.
No. NAD+ is not FDA-approved for any indication and is sold strictly as a research chemical, not a medication or dietary supplement.
Cellular Energy Research — Because NAD+ is a direct participant in mitochondrial electron-transport chain reactions, it is widely studied in research examining cellular energy production and metabolic function across tissue types.
In the US, UK, Canada and Australia, NAD+ is generally sold labeled "for research use only, not for human consumption." It is not approved as a dietary supplement or medication in any of these countries.
NAD+ research is indexed on PubMed under search terms such as "NAD+ cellular metabolism" and "nicotinamide adenine dinucleotide aging."
Compare current prices, purity testing claims and coupon codes across every vendor Compound X tracks.
New guides, vendor comparisons and compound breakdowns every week.